- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: high risk relapsed CD19 and/or CD22 hematological malignancies
Total 38791 results
-
University of PennsylvaniaNot yet recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingFollicular Lymphoma | Primary Mediastinal Large B-Cell Lymphoma (PMBCL) | Diffuse Large-Cell Lymphoma | Transformed Follicular Lymphoma (TFL) | High-grade B-cell Lymphoma (HGBCL)United States
-
Shanghai Tongji Hospital, Tongji University School...Shanghai AbelZeta Ltd.CompletedB Cell LymphomaChina
-
Tianjin Medical University Cancer Institute and...Nanjing Legend Biotech Co.RecruitingB-Cell Non-Hodgkin Lymphoma-Recurrent | B-Cell Non-Hodgkin Lymphoma-RefractoryChina
-
The First Affiliated Hospital with Nanjing Medical...Nanjing Legend Biotech Co.RecruitingRelapsed and Refractory B-cell Non-Hodgkin LymphomaChina
-
Peking UniversityMarino Biotechnology Co., Ltd.UnknownRelapsed or Refractory B-cell LymphomaChina
-
Aibin Liang,MD,Ph.D.RecruitingRefractory or Relapsed B-cell Non-Hodgkin LymphomaChina
-
Shanxi Province Cancer HospitalNovatim Immune Therapeutics (Zhejiang) Co., Ltd.Recruiting
-
Autolus LimitedCompletedDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | DLBCL | Relapsed Diffuse Large B-Cell LymphomaUnited States, United Kingdom
-
National Taiwan University HospitalUnknown
-
M.D. Anderson Cancer CenterCompletedLymphoma | LeukemiaUnited States
-
Shenzhen Second People's HospitalShenzhen Institute for Innovation and Translational MedicineUnknownLymphoma | Chronic Lymphocytic Leukemia | Acute Lymphocytic LeukemiaChina
-
Hoffmann-La RocheRecruitingLymphoma, Non-HodgkinUnited States, Belgium, Australia, Denmark, Italy, Spain, France, United Kingdom
-
Baxalta now part of ShireBaxter Innovations GmbHTerminatedHemophilia APoland, United States, Bulgaria, Serbia, Canada, Russian Federation, Germany, Netherlands, Lithuania, Czechia, Austria, Spain
-
Jichi Medical UniversityTakara Bio Inc.UnknownRelapsed or Refractory B-Cell Non-Hodgkin LymphomaJapan
-
SanofiCompletedLymphoma | Non-HodgkinFrance
-
Beijing Boren HospitalRecruitingAcute Lymphoblastic Leukemia, Pediatric | Acute Lymphoblastic Leukemia, in Relapse | Refractory Acute Lymphoblastic LeukemiaChina
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...RecruitingHaploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion (HAPLOTAB)Myelodysplastic Syndromes | Primary Immunodeficiency Diseases | Hemoglobinopathies | Chronic Myeloid Leukemia | Cytopenia | Severe Aplastic Anemia | Bone Marrow Failure Syndrome | Acute Myeloid Leukemia in Remission | Hemophagocytic Lymphohistiocytoses | Acute Lymphoblastic Leukemia in Remission | Severe...United States
-
Dorothy Sipkins, MD, PhDAcrotech Biopharma Inc.; AmgenWithdrawnB-cell Acute Lymphoblastic LeukemiaUnited States
-
Uppsala UniversityUppsala University Hospital; AFA InsuranceCompletedB-Cell Lymphoma | B-cell LeukemiaSweden
-
Stanford UniversityKyverna TherapeuticsRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
University of Maryland, BaltimoreActive, not recruitingMixed Phenotype Acute Leukemia (MPAL) | Measurable Residual Disease (MRD)United States
-
Peng LiuShanghai East Hospital; Hrain BiotechnologyUnknownMultiple Myeloma in Relapse | Multiple Myeloma ProgressionChina
-
University of Wisconsin, MadisonCompletedLymphomaUnited States
-
Shanghai Ming Ju Biotechnology Co., Ltd.RecruitingAcute Lymphocytic LeukemiaChina
-
Shanghai Unicar-Therapy Bio-medicine Technology...The First Affiliated Hospital of Soochow UniversityRecruitingRelapsed or Refractory Acute Lymphoblastic LeukemiaChina
-
Kai Lin Xu; Jun Nian ZhengNanjing Bioheng Biotech Co., Ltd.UnknownAcute Lymphoblastic LeukemiaChina
-
Shanghai Pudong HospitalUTC Therapeutics Inc.WithdrawnAcute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | B-cell Non-Hodgkin's Lymphoma (B-NHL) | T-Cell Leukemia/Lymphoma, Adult | B-cell Acute Lymphoblastic Leukemia (B-ALL)China
-
Cancer Research UKCompletedChronic Lymphocytic Leukaemia | Indolent B-cell Lymphoma | Waldenström MacroglobulinaemiaUnited Kingdom
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedRecurrent Adult Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic LeukemiaUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingObjective Response RateChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); ADC Therapeutics S.A.RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Philadelphia Chromosome Positive | Blasts 5 Percent or More of Bone Marrow Nucleated Cells | CD22 PositiveUnited States
-
National Cancer Institute (NCI)RecruitingLymphoma, B-Cell | Chronic Lymphocytic Leukemia | B-Cell Chronic Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)Not yet recruitingLeukemia, Lymphocytic, Chronic, B-Cell | B-Cell Chronic Lymphocytic Leukemia | B-Lymphocytic Leukemia, ChronicUnited States
-
Wuhan Union Hospital, ChinaCSPC Pharmaceutical Group LimitedRecruitingB-cell Acute Lymphoblastic Leukemia | B-cell Lymphoma RefractoryChina
-
MorphoSys AGICON Clinical ResearchActive, not recruitingDiffuse Large B-cell LymphomaUnited States, Hungary, Italy, Poland, Spain, Czechia, Germany, Australia, Austria, Canada, Croatia, Finland, France, Israel, Korea, Republic of, New Zealand, Portugal, Romania, Serbia, Singapore, Taiwan, Turkey, United Kingdom
-
Children's Hospital of PhiladelphiaCompletedBone Marrow Failure Syndromes | Immunodeficiencies | Immune Dysregulation SyndromesUnited States
-
Sabz BiomedicalsGene Therapy Research Center, Shariati Hospital, Tehran University of Medical... and other collaboratorsNot yet recruitingRelapsed B Cell Acute Lymphoblastic Leukemia (ALL) | Refractory B Cell Acute Lymphoblastic Leukemia (ALL)Iran, Islamic Republic of
-
Wuhan Sian Medical Technology Co., LtdWuhan Union Hospital, China; Xiangyang Central Hospital; Jingzhou Central Hospital and other collaboratorsRecruitingB Cell Lymphoma | Acute Lymphoblastic LeukemiaChina
-
Affimed GmbHTerminatedRefractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin LymphomaUnited States, Czechia, Germany, Poland
-
Washington University School of MedicineThe Leukemia and Lymphoma Society; Rising Tide Foundation; St. Louis Children...RecruitingAcute Myeloid Leukemia | Aml | AML, Childhood | Acute Myeloid Leukemia, PediatricUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blasts More Than 5 Percent of Bone Marrow Nucleated Cells | B Acute Lymphoblastic Leukemia With t(9;22)(q34... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedB Cell LymphomaUnited States
-
RenJi HospitalGuangdong Ruishun Biotech Co., LtdRecruitingSystemic Lupus Erythematosus | Systemic Sclerosis | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Idiopathic Inflammatory MyopathiesChina
-
Autolus LimitedRecruitingSystemic Lupus ErythematosusUnited Kingdom
-
Wuhan Union Hospital, ChinaWuhan Si'an Medical Technology Co., LtdRecruitingFollicular Lymphoma | Burkitt Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell LymphomaChina
-
Memorial Sloan Kettering Cancer CenterActinium PharmaceuticalsRecruitingDiffuse Large B-cell Lymphoma | B-ALL | DLBCL | DLBCL, Nos Genetic Subtypes | B ALL | Dlbcl-Ci | DLBCL Unclassifiable | DLBCL Activated B-Cell Type | DLBCL Germinal Center B-Cell Type | HGBL | HGBL, NosUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | CD19 PositiveUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Chinese PLA General HospitalWithdrawnNeuromyelitis Optica Spectrum DisorderChina